Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Sanofi and Seagen collaborate to develop and commercialise multiple novel antibody-drug conjugates

Sanofi and Seagen Inc. on Wednesday announced an exclusive collaboration agreement to design, develop, and commercialize antibody-drug conjugates (ADCs) for up to three cancer...

US FDA approves donepezil transdermal patch for treatment of Alzheimer disease

Corium, Inc., a commercial-stage biopharmaceutical company leading the development and commercialization of novel central nervous system (CNS) therapies, announced on Monday the U.S. Food...

Taiwan OBI Pharma enters license agreement with China Odeon Therapeutics

OBI Pharma, Inc. and Odeon Therapeutic, the biopharma companies, have entered into an exclusive license agreement whereby OBI grants rights of OBI-999, a novel...

A major pharmaceutical company Eli Lilly suspends Russia investments, will continue sale of essential drugs

US drugmaker Eli Lilly is scaling back business in Russia, but still pledge to continue supplying critical medicines. Lilly said it will send medicines for...

Italian Stevanato Group expands the boundaries by opening a manufacturing hub in China

The company Stevanato Group, a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today...

FDA approves new version of Philips Capsule Surveillance solution

Royal Philips, a global leader in health technology, announced that Collaboration Live has received expansion of its U.S. Food & Drug Administration 510(k) market...
spot_img

Expert Articles

spot_img